SENATE BILL REPORT

SB 5145

This analysis was prepared by non-partisan legislative staff for the use of legislative members in their deliberations. This analysis is not a part of the legislation nor does it constitute a statement of legislative intent.

As of January 27, 2015

Title: An act relating to the membership of the health technology clinical committee.

Brief Description: Concerning the membership of the health technology clinical committee.

Sponsors: Senators Dammeier, Frockt, Becker, Bailey, Rivers and Brown.

Brief History:

Committee Activity: Health Care: 1/27/15.

SENATE COMMITTEE ON HEALTH CARE

Staff: Evan Klein (786-7483)

Background: The Washington State Health Technology Clinical Committee (HTCC) was established in 2006 to include 11 members appointed by the administrator of the Washington State Health Care Authority (HCA). The committee must include the following:

At least two members of HTCC must have professional experience treating women, children, elderly persons, and people with diverse ethnic and racial backgrounds. Members of HTCC must not contract with or be employed by a health technology manufacturer or participating agency for 18 months before their appointment and throughout their term. Members are immune from civil liability for any official acts performed in good faith as part of HTCC. Members are compensated for participation in the work of HTCC.

The administrator of HCA selects health technologies for review by HTCC. HTCC may also select health technologies for review, pursuant to a petition submitted by an interested party. Upon the selection of a health technology for review, the administrator of HCA contracts for an evidence-based assessment of the technology's safety, efficacy, and cost effectiveness.

For each health technology selected for review, HTCC determines:

Summary of Bill: At least one of the 11-member HTCC must be a medical expert appointed by the Washington State Medical Association.

Appropriation: None.

Fiscal Note: Not requested.

Committee/Commission/Task Force Created: No.

Effective Date: Ninety days after adjournment of session in which bill is passed.

Staff Summary of Public Testimony: PRO: HTCC is a collaborative effort that assists patients and physicians. This bill addresses problems with getting clinical expertise on HTCC and with the administrator of HCA selecting the entire committee.

OTHER: The administrator of HCA must consider specialty, geographic practice area, knowledge, and experience. These criteria are important for selection of anyone on the committee. The objectivity and transparency underlying HTCC should be considered.

Persons Testifying: PRO: Senator Dammeier, prime sponsor; Clif Finch, Abbott.

OTHER: Dan Lessler, Chief Medical Officer, HCA.